Elevance Health
ELV
#98
Rank
$127.90 B
Marketcap
$532.92
Share price
3.41%
Change (1 day)
31.19%
Change (1 year)

P/E ratio for Elevance Health (ELV)

P/E ratio as of December 2022 (TTM): 20.7

According to Elevance Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 20.6536. At the end of 2021 the company had a P/E ratio of 18.5.

P/E ratio history for Elevance Health from 2002 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202118.54.83%
202017.710.03%
201916.1
201715.2-0.4%
201615.36.74%
201514.3

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.